Concurrently, S&P affirmed the “AA+” long-term rating and underlying rating on Inova’s outstanding debt.
The assignment and affirmations are a result of Inova’s strong enterprise profile, characterized by its leading market share, wide array of service offerings and favorable service area. In addition, S&P acknowledged Inova’s strong financial performance, low leverage and high unrestricted reserves.
The outlook is stable, reflecting S&P’s expectation that Inova will maintain its healthy operating results to meet long-term capital needs.
More articles on healthcare finance:
Hospitals are moving to single ratings: Here’s why
Fitch: Minor headwinds coming for US children’s hospitals
Walgreens, CVS, Rite-Aid shares plummet after Amazon buys Pillpack
